Journal article icon

Journal article

Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.

Abstract:

AIMS/HYPOTHESIS: The aim of the study was to examine the impact of statin or omega-3-acid ethyl esters 90 (omega-3 EE90; omega-3-acid ethyl esters 90 refers to a mixture of ethyl esters of n-3 fatty acids) on estimated cardiovascular disease (CVD) risk in community-based people with type 2 diabetes but without known CVD and not taking lipid-lowering therapy. METHODS: A central computer randomised 800 patients in 59 UK general practices to atorvastatin (n = 401, 20 mg/day) or placebo (n = 399...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1007/s00125-008-1179-5

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, OCDEM, Biomedical Research Centre
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Primary Care Health Sciences, Biomedical RC
Stratton, IM More by this author
Expand authors...
Journal:
Diabetologia
Volume:
52
Issue:
1
Pages:
50-59
Publication date:
2009-01-05
DOI:
EISSN:
1432-0428
ISSN:
0012-186X
URN:
uuid:7553736c-b9cf-49e7-a15f-7ba135aa5ff6
Source identifiers:
16931
Local pid:
pubs:16931

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP